Loading clinical trials...
Loading clinical trials...
A Prospective, Single-arm, Open-label, Phase 2 Study to Evaluate Efficacy and Safety of DA-EPOCH Regimen for Non-Hodgkin's Lymphoma With Hemophagocytic Lymphohistiocytosis
Conditions
Interventions
DA-EPOCH
Locations
4
China
ChangZhou No.2 People's Hospital
Changzhou, Jiangsu, China
HuaiAn First People's Hospital
HuaiAn, Jiangsu, China
JiangSu Province Hospital
Nanjing, Jiangsu, China
WuXi People's Hospital
Wuxi, Jiangsu, China
Start Date
June 1, 2012
Primary Completion Date
October 1, 2018
Completion Date
April 1, 2019
Last Updated
February 15, 2019
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions